Skip to search formSkip to main contentSkip to account menu

enocitabine

Known as: BH-AC, Docosanamide, N-(1-beta-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)-, N(4)-behenoyl ara-C 
A pyrimidine antimetabolite converted to Cytarabine in the body. (NCI)
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Antineoplastic AgentsAntiviral AgentsCytarabine

Narrower (1)

NSC 239336
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Aclarubicin plus behenoyl cytarabine and prednisolone for previously treated acute myeloid leukemia patients
This study analysed the clinical outcome of salvage therapy consisting of aclarubicin (ACR) plus behenoyl cytarabine (BHAC) and… 
Review
2005
Review
2005
Therapy‐related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2)
We describe a patient who developed myelodysplastic syndrome over 2 years after achieving complete remission of acute myeloid… 
2001
2001
Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG)
Abstract. All-trans-retinoic acid (ATRA) has been incorporated in front-line therapy for newly diagnosed acute promyelocytic… 
2000
2000
Novel drug delivery system using autologous fibrin glue--release properties of anti-cancer drugs.
To clarify the release properties of anti-cancer drugs from fibrin glue, a study was performed using several anti-cancer drugs… 
1999
1999
Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy. The Japan Adult Leukemia Study Group.
1997
1997
All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy
Abstract We analyzed the results of treating patients with newly diagnosed acute promyelocytic leukemia (APL) with all-trans… 
1995
1995
A t(11;14)(p13;q11) specific for T-cell malignancies in acute megakaryoblastic leukemia.
1994
1994
All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
We have conducted four prospective multicenter studies for acute promyelocytic leukemia (APL) using oral 45 mg/m2 all-trans… 
1991
1991
Intensive individualized induction therapy with behenoyl cytarabine, daunorubicin and 6-mercaptopurine followed by intensive consolidation including intermediate-dose continuous cytarabine…
Forty-one consecutive adult patients with acute myeloid leukemia (AML) were treated with an intensive individualized induction… 
Highly Cited
1969
Highly Cited
1969
Studies on the lysis of red cells and bimolecular lipid leaflets by synthetic lysolecithins, lecithins and structural analogs.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)